Detalles de la búsqueda
1.
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38800943
2.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804599
3.
Bendamustine lymphodepletion is a well-tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B-cell lymphoma.
Am J Hematol
; 98(11): 1751-1761, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37668287
4.
Neutropenic ulcers in oncology: terminology, diagnosis, and management.
Support Care Cancer
; 31(12): 716, 2023 Nov 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991547
5.
Chronic oral graft-versus-host disease: induction and maintenance therapy with photobiomodulation therapy.
Support Care Cancer
; 29(3): 1387-1394, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-32666212
6.
Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(6): 1084-1090, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32035275
7.
Long-Term Outcomes of Patients with Acute Myelogenous Leukemia Treated with Myeloablative Fractionated Total Body Irradiation TBI-Based Conditioning with a Tacrolimus- and Sirolimus-Based Graft-versus-Host Disease Prophylaxis Regimen: 6-Year Follow-Up from a Single Center.
Biol Blood Marrow Transplant
; 26(2): 292-299, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31536825
8.
Ruxolitinib as Salvage Therapy for Chronic Graft-versus-Host Disease.
Biol Blood Marrow Transplant
; 25(2): 265-269, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30201397
9.
Real-world experience of axicabtagene ciloleucel, a CD19-directed CAR T-cell therapy, in the second-line treatment of early relapsed or primary refractory large B-cell lymphoma.
Br J Haematol
; 2024 May 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38797530
10.
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.
Haematologica
; 103(10): 1662-1668, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903756
11.
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
Biol Blood Marrow Transplant
; 23(6): 922-929, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28267593
12.
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue.
Biol Blood Marrow Transplant
; 23(8): 1264-1268, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434928
13.
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Biol Blood Marrow Transplant
; 23(4): 618-624, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087456
14.
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of TP53 mutational status.
Haematologica
; 102(12): 2030-2038, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971906
15.
Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis.
Biol Blood Marrow Transplant
; 22(1): 164-9, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26303102
16.
Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation.
Support Care Cancer
; 23(11): 3141-7, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25791390
17.
Results of a Phase II Trial of Allogeneic Hematopoietic Stem Cell Transplantation Using 90Y-Ibritumomab Tiuxetan (Zevalin) in Combination With Fludarabine and Melphalan in Patients With High-Risk B-Cell Non-Hodgkin's Lymphoma.
Clin Lymphoma Myeloma Leuk
; 23(9): e268-e276, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37301631
18.
WT1-mutated acute myeloid leukemia is sensitive to fludarabine-based chemotherapy and conditioning regimens.
Leuk Lymphoma
; 64(11): 1811-1821, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37533373
19.
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial.
Lancet Haematol
; 10(1): e14-e23, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36403579
20.
Sequential bortezomib, dexamethasone, and thalidomide maintenance therapy after single autologous peripheral stem cell transplantation in patients with multiple myeloma.
Biol Blood Marrow Transplant
; 18(3): 486-92, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198542